42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
[defid] => VWS-WOO-08-941410
[request_id] =>
)
=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
[id] => f53fb797-4eb8-49ca-a1ee-29f2af40924b
[Document ID] => 941410
[Document naam] => 4.b.1._Additional safeguards securing the robustness & independence of the scientific review process for MAAs for COVID-19.pdf.pdf
[Bestandsnaam] =>
[Beoordeling] =>
[Beoordelingsgrond] =>
[Toelichting] =>
[Publieke link] =>
[Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3405320-1033219-PDO/document/VWS-WOO-08-941410
[Opgeschort] =>
[Definitief ID] => VWS-WOO-08-941410
[Status] => shiningstar
[FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3405320-1033219-PDO
[DocumentPublicationDate] => 4 november 2020
[DocumentStatusCheckedDate] => 2026-04-29 12:02:04.610476
[DocumentStatusCheckedResult] => 200
[SourceFileType] =>
[Tags] =>
[Besluit] =>
[ModifiedDate] => 2025-09-22 04:55:03
[DeletedDate] =>
[BesluitURL] =>
[CreatedDate] => 2025-06-19 18:31:59
[DocumentDownloadLink] =>
[DigestLaatsteControleDatum] => 2025-09-22 04:55:03
)
Document: VWS-WOO-08-941410
Klik om te vergroten
Document correcties
Geregistreerde datum: 20201104
Geregistreerde documentnaam: 4.b.1._Additional safeguards securing the robustness & independence of the scientific review process for MAAs for COVID-19.pdf.pdf
Document attributen
| Tag | Waarde | Datum |
|---|---|---|
| Request_Omvang openbaarmaking_linkname_1 | Inventarislijst | 2025-06-22 23:39:41 |
| Request_Omvang openbaarmaking_documenten | 8.199 | 2025-06-22 23:39:41 |
| Request_Omvang openbaarmaking_paginas | 34.478 | 2025-06-22 23:39:41 |
| Request_Omvang openbaarmaking_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3405320-1033219-PDO/file/download/inventory | 2025-06-22 23:39:41 |
| document_documentName | 4.b.1._Additional safeguards securing the robustness & independence of the scientific review process for MAAs for COVID-19.pdf.pdf | 2025-06-22 23:39:41 |
| document_documentType | 2025-06-22 23:39:41 | |
| document_documentPublicationDate | 2020-11-04 | 2025-06-22 23:39:41 |
| document_documentNumber | VWS-WOO-08-941410 | 2025-06-22 23:39:41 |
| document_SectionDownloadButton | 0 | 2025-06-22 23:39:41 |
| document_SectionHTMLDataDivs | 2 | 2025-06-22 23:39:41 |
| document_SectionAbout | 1 | 2025-06-22 23:39:41 |
| About_Datum document | 4 november 2020 | 2025-06-22 23:39:41 |
| About_Type bronbestand | PDF, 7 pagina's | 2025-06-22 23:39:41 |
| About_Type bronbestand_paginas | 7 | 2025-06-22 23:39:41 |
| About_Download als | PDF (2.9 MB) | 2025-06-22 23:39:41 |
| About_Documentnummer | 941410 | 2025-06-22 23:39:41 |
| About_Beoordeling | Openbaarmaking | 2025-06-22 23:39:41 |
| About_Gelakte gegevens | Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten. | 2025-06-22 23:39:41 |
| About_Gelakte gegevens_linkhref_1 | mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over 4.b.1._Additional safeguards securing the robustness & independence of the scientific review process for MAAs for COVID-19.pdf.pdf (documentnummer 1ee694b8-e8b8-6bc4-b40e-2b7b8111b989) | 2025-06-22 23:39:41 |
| About_Gelakte gegevens_linkname_1 | Laat het ons weten | 2025-06-22 23:39:41 |
| document_SectionRequest | 1 | 2025-06-22 23:39:41 |
| Request_Onderdeel van | Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode november 2020 | 2025-06-22 23:39:41 |
| Request_Onderdeel van_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3405320-1033219-PDO | 2025-06-22 23:39:41 |
| Request_Onderdeel van_linkname_1 | Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode november 2020 | 2025-06-22 23:39:41 |
| Request_Samenvatting verzoek | De minister van Volksgezondheid, Welzijn en Sport heeft op 10 augustus 2022 een besluit genomen op verzoeken in het kader van de Wet open overheid. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties en Medicatie over de periode november 2020. | 2025-06-22 23:39:41 |
| Request_Periode | November 2020 | 2025-06-22 23:39:41 |
| Request_Type besluit | Woo-besluit | 2025-06-22 23:39:41 |
| Request_Datum besluit | 10 augustus 2022 | 2025-06-22 23:39:41 |
| Request_Omvang openbaarmaking | 8.199 documenten, 34.478 pagina's Inventarislijst | 2025-06-22 23:39:41 |
| DocumentDownload_linkhref | https://open.minvws.nl/dossier/VWS-WOO/3405320-1033219-PDO/file/download/document/1ee694b8-e8b8-6bc4-b40e-2b7b8111b989 | 2025-04-20 00:37:39 |
| DocumentDownload_proposed_filename (lokale kopie) | VWS-WOO-08-941410.pdf | 2025-04-20 00:37:39 |
| DocumentDownload_linkname | Download (pdf, 2.9 MB) | 2025-04-20 00:37:39 |
Archiefversies (7 rijen)
Archiefrij 1 — 2025-09-07 17:32:06
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-941410.pdf
documentName: VWS-WOO-08-941410.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 3040267
documentCompressRatio: 0
documentDateModified: 2025-09-07 17:32:06
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:32:06
lastSeen: 2025-09-07 17:32:06
text: 941410
EUROPEAN MEDICINES AGENCY
0[88)©LEMEDICINES 58.8LHi
Additional safeguards (tobe) put inplace
forsecuring the robustness and
independence ofthe scientific review
process forMAAs forCOVID-19 treatments
Management Board meeting 1October 2020
Agenda item 6.b, forendorsement
Presented byNoél Wathi...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: db5c25ec0b8a10868d40cedd0d9c2abf4d13501c709718ff421288fb43fbd68f
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:10.664062+00
Id: folder_import_74790_9d6659ff25e7bb55e145effc276a2704
textDigestSHA256: 3bae07c1d09ce60076e3b3b46ea9a2f8d5f4c03236616f487545297c0dac9755
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-941410
Archiefrij 2 — 2025-09-04 16:59:32
fromFile: VWS-WOO-3405320-1033219-PDO-1f026c98-54a2-616e-b0bd-65673e0af118.zip
fromFilePath: ../../archieven_files/VWS-WOO-3405320-1033219-PDO-1f026c98-54a2-616e-b0bd-65673e0af118.zip
documentName: VWS-WOO-08-941410.pdf
documentType: pdf
documentCompressedSize: 2025684
documentSize: 3040267
documentCompressRatio: 66.62849019510458
documentDateModified: 2025-05-01 20:20:14
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 16:59:32
lastSeen: 2025-09-04 16:59:32
text: 941410
EUROPEAN MEDICINES AGENCY
0[88)©LEMEDICINES 58.8LHi
Additional safeguards (tobe) put inplace
forsecuring the robustness and
independence ofthe scientific review
process forMAAs forCOVID-19 treatments
Management Board meeting 1October 2020
Agenda item 6.b, forendorsement
Presented byNoél Wathi...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: db5c25ec0b8a10868d40cedd0d9c2abf4d13501c709718ff421288fb43fbd68f
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: VWS-WOO-3405320-1033219-PDO-1f026c98-54a2-616e-b0bd-65673e0af118.zip_410
textDigestSHA256: 3bae07c1d09ce60076e3b3b46ea9a2f8d5f4c03236616f487545297c0dac9755
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-941410
Archiefrij 3 — 2025-09-04 16:37:56
fromFile: VWS-WOO-3405320-1033219-PDO-1f03af74-9059-6598-b46a-e1433ef450d1.zip
fromFilePath: ../../archieven_files/VWS-WOO-3405320-1033219-PDO-1f03af74-9059-6598-b46a-e1433ef450d1.zip
documentName: VWS-WOO-08-941410.pdf
documentType: pdf
documentCompressedSize: 2025684
documentSize: 3040267
documentCompressRatio: 66.62849019510458
documentDateModified: 2025-05-27 12:38:36
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 16:37:56
lastSeen: 2025-09-04 16:37:56
text: 941410
EUROPEAN MEDICINES AGENCY
0[88)©LEMEDICINES 58.8LHi
Additional safeguards (tobe) put inplace
forsecuring the robustness and
independence ofthe scientific review
process forMAAs forCOVID-19 treatments
Management Board meeting 1October 2020
Agenda item 6.b, forendorsement
Presented byNoél Wathi...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: db5c25ec0b8a10868d40cedd0d9c2abf4d13501c709718ff421288fb43fbd68f
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: VWS-WOO-3405320-1033219-PDO-1f03af74-9059-6598-b46a-e1433ef450d1.zip_392
textDigestSHA256: 3bae07c1d09ce60076e3b3b46ea9a2f8d5f4c03236616f487545297c0dac9755
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-941410
Archiefrij 4 — 2025-03-18 09:30:25
fromFile: 2024.075-VWS-WOO-3405320-1033219-PDO.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2024.075-VWS-WOO-3405320-1033219-PDO.zip
documentName: VWS-WOO-08-941410.pdf
documentType: pdf
documentCompressedSize: 2021145
documentSize: 3040267
documentCompressRatio: 66.47919409709739
documentDateModified: 2025-01-08 16:23:22
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-18 09:30:25
lastSeen: 2025-03-18 09:30:25
text: 941410
EUROPEAN MEDICINES AGENCY
0[88)©LEMEDICINES 58.8LHi
Additional safeguards (tobe) put inplace
forsecuring the robustness and
independence ofthe scientific review
process forMAAs forCOVID-19 treatments
Management Board meeting 1October 2020
Agenda item 6.b, forendorsement
Presented byNoél Wathi...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 3bae07c1d09ce60076e3b3b46ea9a2f8d5f4c03236616f487545297c0dac9755
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 324101
textDigestSHA256: 3bae07c1d09ce60076e3b3b46ea9a2f8d5f4c03236616f487545297c0dac9755
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-941410
Archiefrij 5 — 2025-02-27 09:25:04
fromFile: 2023.057-VWS-WOO-3405320-1033219-PDO.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.057-VWS-WOO-3405320-1033219-PDO.zip
documentName: VWS-WOO-08-941410.pdf
documentType: pdf
documentCompressedSize: 2021145
documentSize: 3040267
documentCompressRatio: 66.47919409709739
documentDateModified: 2025-01-08 16:23:22
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:04
lastSeen: 2025-02-27 09:25:04
text: 941410
EUROPEAN MEDICINES AGENCY
0[88)©LEMEDICINES 58.8LHi
Additional safeguards (tobe) put inplace
forsecuring the robustness and
independence ofthe scientific review
process forMAAs forCOVID-19 treatments
Management Board meeting 1October 2020
Agenda item 6.b, forendorsement
Presented byNoél Wathi...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 3bae07c1d09ce60076e3b3b46ea9a2f8d5f4c03236616f487545297c0dac9755
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 236655
textDigestSHA256: 3bae07c1d09ce60076e3b3b46ea9a2f8d5f4c03236616f487545297c0dac9755
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-941410
Archiefrij 6 — 2025-02-18 12:18:13
fromFile: VWS-WOO-3405320-1033219-PDO-14463f095e9ec956e456d616d78134ed0ddfad1e2cf89cd8bd19f80bc5928102.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\VWS-WOO-3405320-1033219-PDO-14463f095e9ec956e456d616d78134ed0ddfad1e2cf89cd8bd19f80bc5928102.zip
documentName: VWS-WOO-08-941410.pdf
documentType: pdf
documentCompressedSize: 2021145
documentSize: 3040267
documentCompressRatio: 66.47919409709739
documentDateModified: 2025-01-08 16:23:22
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:13
lastSeen: 2025-02-18 12:18:13
text: 941410
EUROPEAN MEDICINES AGENCY
0[88)©LEMEDICINES 58.8LHi
Additional safeguards (tobe) put inplace
forsecuring the robustness and
independence ofthe scientific review
process forMAAs forCOVID-19 treatments
Management Board meeting 1October 2020
Agenda item 6.b, forendorsement
Presented byNoél Wathi...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 3bae07c1d09ce60076e3b3b46ea9a2f8d5f4c03236616f487545297c0dac9755
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 108190
textDigestSHA256: 3bae07c1d09ce60076e3b3b46ea9a2f8d5f4c03236616f487545297c0dac9755
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-941410
Archiefrij 7 — 2025-02-18 12:18:03
fromFile: Besluit__dossier_nr_-14463f095e9ec956e456d616d78134ed0ddfad1e2cf89cd8bd19f80bc5928102.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-14463f095e9ec956e456d616d78134ed0ddfad1e2cf89cd8bd19f80bc5928102.zip
documentName: VWS-WOO-08-941410-4.b.1._Additional_safeguards__securing_the_robustness___independence_of_the_scientific_review_process_for_MAAs_for_COVID-19.pdf.pdf
documentType: pdf
documentCompressedSize: 2021145
documentSize: 3040267
documentCompressRatio: 66.47919409709739
documentDateModified: 2024-08-27 10:34:54
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:03
lastSeen: 2025-02-18 12:18:03
text: leeg!
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: n/a
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 42543
textDigestSHA256: leeg!
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-941410
(dit is ook een speeltuin)